For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Op-Eds
Plants Bad for the Environment? Celebrities Causing Frogs to Croak?
Could it be that celebrities are planting the forests that are causing the global warming that is growing the bacteria that are wiping out the…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY The EPA proposes to change the standard for testing gas mileage…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. INTERNET Google’s new video service raises questions about copyright protection technology. CEI Expert Available for…
Op-Eds
Fill the Moat, Lower the Portcullis
The issues surrounding the possibility of a pandemic of the H5N1 strain of avian flu are extraordinarily complex, encompassing aspects of medicine, epidemiology,…
Op-Eds
Flu pandemic prevention
This month's outbreak of H5N1 avian flu in Turkey—as many as 50 human cases and several deaths—looks very like what we might see…
Products
Europe’s Global REACH: Chemical Regulations in Europe Promise Worldwide Costs
This month, the European Parliament voted in favor of a massive new expansion of the European Union's (EU) chemical regulations. Known as REACH—which stands for…